Technology

AddToAny

Google+ Facebook Twitter Twitter

New breathalyser for disease

Owlstone Medical has announced the launch of its Breath Biopsy Kits.

New breathalyser for disease

 

The new product range allows academic, clinical and pharmaceutical researchers to quickly discover and validate breath-based biomarkers in early detection and precision medicine research activities.

Owlstone Medical’s Breath Biopsy platform is a new diagnostic modality capable of detecting biomarkers of disease, and also exogenous compounds, such as volatile drug metabolites, in breath.

The company’s ReCIVA Breath Sampler and new Breath Biopsy Kits ensure consistent and reliable collection of breath samples.

owlstonemedical.com

Related Articles

p8-13-News-Blood-testing--Istock--520292052.jpg

Blood sample analysis

Nightingale Health will analyse the biomarker profiles of 500,000 blood samples from UK Biobank. 

Markers Biomarker Protein in Ovarian Cancer Sciencephoto

Clinical chemistry classics: tumour markers

This series continues with a brief review of pioneering work in the development, analysis and clinical application of important tumour markers, with two examples from the CA serum series – CA125 and CA15-3.

Tumor Markers Human Chorionic Gonadotropin Molecule Science Photo

Clinical chemistry classics: tumour markers

This short series continues with a brief review of pioneering work in the development and clinical application of two important tumour markers – serum alpha fetoprotein and urine and serum human chorionic gonadotropin.

Top